Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092255166> ?p ?o ?g. }
- W2092255166 endingPage "2026" @default.
- W2092255166 startingPage "2023" @default.
- W2092255166 abstract "Resistance is one limitation of sorafenib in the treatment of hepatocellular carcinoma (HCC). Insulin-like growth factor-1 receptor (IGF-1R) is involved in cancer cell proliferation. To assess the potential synergistic antitumor effects of picropodophyllin (PPP), an IGF-1R inhibitor, HLF and PLC/PRL/5, HCC cells were treated with PPP alone or PPP in combination with sorafenib, a multikinase inhibitor. Normal human umbilical vein endothelial cells (HUVECs) were also used to analyze the antiangiogenic effects of the drugs. HCC cells and HUVECs were cultured on 96‑well plates, and then treated with PPP, with and without the addition of sorafenib. A 3‑(4,5‑dimethylthiazol‑2‑yl)‑5‑(3‑carboxymethoxyphenyl)‑2‑(4‑sulfophenyl)‑2H‑tetrazolium inner salt assay and hematoxylin and eosin staining were then performed 48 h later. The HCC cells were also analyzed using scratch assays and hematoxylin and eosin staining after 48 h. The proliferation of HLF, PLC/PRF/5 and HUVEC cells was suppressed by the combination of 0.2 µM PPP and 3 µM sorafenib more effectively than by 10 µM sorafenib alone. The motility of HLF and PLC/PRF/5 cells was also suppressed to a greater extent with the combination of PPP at 0.2 µM and sorafenib at 3 µM than with sorafenib at 10 µM alone. The cells that had been treated with 0.2 µM PPP and 3 µM sorafenib also exhibited pyknotic nuclei, which is characteristic of apoptosis. In conclusion, PPP enhanced sorafenib‑mediated suppression of proliferation and motility in HCC cells. Therefore, the combination of PPP and sorafenib may exert antitumor and antiangiogenic effects." @default.
- W2092255166 created "2016-06-24" @default.
- W2092255166 creator A5011137466 @default.
- W2092255166 creator A5022499425 @default.
- W2092255166 creator A5039764681 @default.
- W2092255166 creator A5058088666 @default.
- W2092255166 creator A5065724424 @default.
- W2092255166 creator A5085203051 @default.
- W2092255166 date "2014-08-27" @default.
- W2092255166 modified "2023-09-29" @default.
- W2092255166 title "Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells" @default.
- W2092255166 cites W12620930 @default.
- W2092255166 cites W1511815713 @default.
- W2092255166 cites W1971837077 @default.
- W2092255166 cites W1974342793 @default.
- W2092255166 cites W1991388198 @default.
- W2092255166 cites W2011480667 @default.
- W2092255166 cites W2012206696 @default.
- W2092255166 cites W2015116198 @default.
- W2092255166 cites W2017592190 @default.
- W2092255166 cites W2021942056 @default.
- W2092255166 cites W2023447208 @default.
- W2092255166 cites W2070396671 @default.
- W2092255166 cites W2073391234 @default.
- W2092255166 cites W2076627593 @default.
- W2092255166 cites W2085547877 @default.
- W2092255166 cites W2087980926 @default.
- W2092255166 cites W2095198784 @default.
- W2092255166 cites W2140016882 @default.
- W2092255166 cites W2164018180 @default.
- W2092255166 cites W2164720489 @default.
- W2092255166 doi "https://doi.org/10.3892/ol.2014.2484" @default.
- W2092255166 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4186500" @default.
- W2092255166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25289088" @default.
- W2092255166 hasPublicationYear "2014" @default.
- W2092255166 type Work @default.
- W2092255166 sameAs 2092255166 @default.
- W2092255166 citedByCount "5" @default.
- W2092255166 countsByYear W20922551662019 @default.
- W2092255166 countsByYear W20922551662021 @default.
- W2092255166 countsByYear W20922551662022 @default.
- W2092255166 crossrefType "journal-article" @default.
- W2092255166 hasAuthorship W2092255166A5011137466 @default.
- W2092255166 hasAuthorship W2092255166A5022499425 @default.
- W2092255166 hasAuthorship W2092255166A5039764681 @default.
- W2092255166 hasAuthorship W2092255166A5058088666 @default.
- W2092255166 hasAuthorship W2092255166A5065724424 @default.
- W2092255166 hasAuthorship W2092255166A5085203051 @default.
- W2092255166 hasBestOaLocation W20922551661 @default.
- W2092255166 hasConcept C121608353 @default.
- W2092255166 hasConcept C125473707 @default.
- W2092255166 hasConcept C126322002 @default.
- W2092255166 hasConcept C142724271 @default.
- W2092255166 hasConcept C1491633281 @default.
- W2092255166 hasConcept C185592680 @default.
- W2092255166 hasConcept C190283241 @default.
- W2092255166 hasConcept C2776231280 @default.
- W2092255166 hasConcept C2778019345 @default.
- W2092255166 hasConcept C2778695046 @default.
- W2092255166 hasConcept C2781018059 @default.
- W2092255166 hasConcept C29537977 @default.
- W2092255166 hasConcept C502942594 @default.
- W2092255166 hasConcept C55493867 @default.
- W2092255166 hasConcept C58207958 @default.
- W2092255166 hasConcept C62112901 @default.
- W2092255166 hasConcept C71924100 @default.
- W2092255166 hasConcept C74864618 @default.
- W2092255166 hasConcept C86803240 @default.
- W2092255166 hasConcept C95444343 @default.
- W2092255166 hasConcept C96232424 @default.
- W2092255166 hasConcept C98274493 @default.
- W2092255166 hasConceptScore W2092255166C121608353 @default.
- W2092255166 hasConceptScore W2092255166C125473707 @default.
- W2092255166 hasConceptScore W2092255166C126322002 @default.
- W2092255166 hasConceptScore W2092255166C142724271 @default.
- W2092255166 hasConceptScore W2092255166C1491633281 @default.
- W2092255166 hasConceptScore W2092255166C185592680 @default.
- W2092255166 hasConceptScore W2092255166C190283241 @default.
- W2092255166 hasConceptScore W2092255166C2776231280 @default.
- W2092255166 hasConceptScore W2092255166C2778019345 @default.
- W2092255166 hasConceptScore W2092255166C2778695046 @default.
- W2092255166 hasConceptScore W2092255166C2781018059 @default.
- W2092255166 hasConceptScore W2092255166C29537977 @default.
- W2092255166 hasConceptScore W2092255166C502942594 @default.
- W2092255166 hasConceptScore W2092255166C55493867 @default.
- W2092255166 hasConceptScore W2092255166C58207958 @default.
- W2092255166 hasConceptScore W2092255166C62112901 @default.
- W2092255166 hasConceptScore W2092255166C71924100 @default.
- W2092255166 hasConceptScore W2092255166C74864618 @default.
- W2092255166 hasConceptScore W2092255166C86803240 @default.
- W2092255166 hasConceptScore W2092255166C95444343 @default.
- W2092255166 hasConceptScore W2092255166C96232424 @default.
- W2092255166 hasConceptScore W2092255166C98274493 @default.
- W2092255166 hasIssue "5" @default.
- W2092255166 hasLocation W20922551661 @default.
- W2092255166 hasLocation W20922551662 @default.
- W2092255166 hasLocation W20922551663 @default.
- W2092255166 hasLocation W20922551664 @default.